DEC2 Antibodies

Santa Cruz Biotechnology supplies a comprehensive collection of DEC2 monoclonal antibodies for research focused on understanding DEC2 protein functions. DEC2 monoclonal antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). DEC2, also known as BHLHE41, is a basic helix-loop-helix transcription factor that plays a critical role in regulating circadian rhythms and cellular responses to hypoxia. DEC2 functions are essential for maintaining normal physiological processes and have been implicated in various biological pathways, including sleep regulation and tumorigenesis. Understanding DEC2 mechanisms can provide insights into potential therapeutic targets in sleep disorders and cancer. Researchers worldwide utilize DEC2 monoclonal antibodies to advance their studies in circadian biology and cancer research. DEC2 monoclonal antibodies enable precise detection and analysis of DEC2 expression patterns across different tissues and experimental conditions. Santa Cruz Biotechnology monoclonal antibodies support researchers in making meaningful discoveries that contribute to advancing scientific knowledge in sleep disorders and cancer research.